Arvinas, Inc. revenue breakdown overview

Arvinas, Inc. revenue for the last year amounted to 78.50 M USD, the most of which — 78.50 M USD — came from its highest performing source at the moment, Protein Degradation Therapeutics, the year earlier bringing 131.40 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Arvinas, Inc. 78.50 M USD, and the year before that — 131.40 M USD.